drugset / Trial / NCT03525652
Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment
Phase 1/2
Unknown
30 enrolled
The First Affiliated Hospital of Guangdong Pharmaceutical University
Guangzhou Anjie Biomedical Technology Co., Ltd. · collabUniversity of Technology, Sydney · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This study is to evaluate the safety and efficacy of a therapeutic vaccine in combination with PD-1 knockout T cells in the treatment of advanced prostate cancer.
Timeline
- Start
- 2018-02-22
- Primary completion
- 2021-02-22
- Completion
- 2021-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PD-1 Knockout T Cells | Cell therapy | — | — |
| Subject | Therapeutic vaccine | Vaccine | — | — |